FdaApplication
NDA 020192
Identifiers
- fda_app_no: NDA020192
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1992-12-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMISIL | TERBINAFINE HYDROCHLORIDE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM;TOPICAL |
1 product